- Author: Ju-Sik Yun, Kook-Joo Na, Jay-Key Chekar, In-Seok Jeong, Sang-Yun Song, Sang-Gi Oh
- Date: 2010/04/05
- Journal: Journal of Chest Surgery;43(2);144-149
- PMID:
- PMCID:
- DOI: https://doi.org/10.5090/kjtcs.2010.43.2.144
Abstract
Background
Many studies have demonstrated the various therapeutic options for treating hemoptysis caused by inflammatory lung disease. However, there is debate over the surgical management of the ongoing hemoptysis. Therefore, we evaluated the clinical results of pulmonary resection that was done due to hemoptysis in patients with concomitant inflammatory lung disease.
Material and Method
We performed a retrospective analysis of 75 patients who received pulmonary resection for hemoptysis and concomitant inflammatory lung disease between 2001 and 2007. The mean age was years old, and the male; female ratio was 52: 23.
Result
The underlying disease was aspergilloma in 30 patients (40%), pulmonary tuberculosis in 20 patients, bronchiectasis in 18 patients and other causes in 7 patients. The surgical treatment included lobectomy in 55 patients, bilobectony in 2 patients, pneumonectomy in 17 patients and wedge resection in 1 patient. There were 3 early deaths, and the causes of death were pneumonia in 1 patient and BPF in 2 patients. The early mortality was statistically higher for such risk factors as a preoperative Hgb level< 10 g/dL, COPD and an emergency operation.
Conclusion
In conclusion, pulmonary resection for treating hemoptysis showed the acceptable range of mortality and it was an effective method for the management of hemoptysis in patients with inflammatory lung disease. However, relatively high rates of mortality and morbidity were noted for an emergency operation, and so meticulous care is needed in this situation.